Alan Kalton & Graham Rapier talk through the Top 5 AI Myths getting in the way of your digital transformation efforts. Read the full article here.
As virtual engagements become a fixture of the new omnichannel commercial model, how can pharma improve its approach? Aktana’s Emanuele Triggiano writes about the importance of message continuity, relevance and how companies can use AI to achieve both for PM360 Magazine. Read the full article here.
The pandemic pressure-tested several key commercial shifts that pharma has been talking about for years. James Anderson and Bruce Carlson reflect on what we’ve learned about the future of HCP engagement for Bio-IT world. Read the full article here.
By empowering leaner teams to reach HCPs more efficiently, AI is set to be the great commercial equalizer for emerging and mid-sized pharma. James Anderson breaks down how AI can help SMB organizations thrive in a dynamic market for Coruzant Technologies. Read the full article here.
On the other side of the pandemic lies a new era of innovation for the life sciences industry—especially when it comes to HCP engagement. Aktana’s James Anderson shares five key takeaways for using AI to transform commercial execution with MedCity News. Read the full article here.
Antares Pharma and other growing innovators leverage new class of AI technology to provide customers with a true omnichannel experience SAN FRANCISCO, CA March 23, 2021 (GLOBE NEWSWIRE) — Aktana, the global leader in intelligent customer engagement for the life sciences industry, announced the release of a dedicated configuration of their AI offering tailored to the […]
From remote engagement to AI-driven personalization, COVID’s impact on the pharma industry will be felt long after the pandemic subsides. Jay Borowiecki and other industry leaders predict which changes will fade and which will redefine the way we engage with HCPs for MedAdNews. Read the full article here.
Aktana’s Derek Choy joins leaders from Veeva, Salesforce, Antares and Monocl to break down how life sciences commercial teams are adapting to the digital shift accelerated by the pandemic. Read more from MM+M here
How will AI transform commercial life sciences in 2021? From a more agile approach to product launch to the decentralization of data science teams, Aktana’s Jim Anderson, Pini Ben-Or and Alan Kalton weigh in on the changes we can expect in the year ahead.
Understanding the “why” behind any recommendation is critical for adoption. In the December issue of Pharmaceutical-commerce, Derek Choy breaks down how explainable AI provides the context users need to trust AI and bring about true commercial transformation. Read the full article here.